Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conditions or Focus of Study”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Large-scale testing (Phase 3)Study completedNCT03138512
What this trial is testing

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

Who this might be right for
Carcinoma, Renal Cell
Bristol-Myers Squibb 1,641
Early research (Phase 1)Study completedNCT06372236
What this trial is testing

UTAA06 Injection for Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Conditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor
Peking University 10
Not applicableStudy completedNCT07658209
What this trial is testing

AI-Supported E-Learning for Pressure Injury Prevention

Who this might be right for
Conditions or Focus of StudyPressure Injury PreventionPressure Ulcer Prevention+1 more
Kilis 7 Aralik University 162
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Not applicableStudy completedNCT03094078
What this trial is testing

Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin by English-speaking Patients

Who this might be right for
The Study Focus on no Specific Condition
Assistance Publique - Hôpitaux de Paris 300
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Post-approval studies (Phase 4)Study completedNCT05533814
What this trial is testing

Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

Who this might be right for
Epilepsy
Eisai Korea Inc. 125
Early research (Phase 1)WithdrawnNCT02215629
What this trial is testing

Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Verastem, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06388707
What this trial is testing

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Who this might be right for
Drug Resistant EpilepsyEpilepsySeizures, Focal+2 more
NaviFUS Corporation 8
Not applicableWithdrawnNCT03094065
What this trial is testing

Interpretation of Health News Items Reporting Results of Pre-clinical Studies With or Without Spin By French-speaking Patients

Who this might be right for
The Study Focus on no Specific Condition
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Study completedNCT05536804
What this trial is testing

Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Who this might be right for
OverweightObesityChronic Kidney Disease+2 more
Eli Lilly and Company 134
Large-scale testing (Phase 3)WithdrawnNCT04114630
What this trial is testing

Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab

Who this might be right for
Migraine
Novartis Pharmaceuticals
Not applicableStudy completedNCT03673878
What this trial is testing

Prevalence of a Localized or Diffuse Pruritus in a Population With One or Several, Primitive or Secondary, Brain Tumor(s)

Who this might be right for
PruritusBrain Tumor
University Hospital, Brest 200
Not applicableLooking for participantsNCT07307664
What this trial is testing

Increasing Germline Genetic Testing for Patients With Cancer

Who this might be right for
Hereditary Pancreatic CancerConditions or Focus of StudyHereditary Breast Cancer+1 more
Josh Peterson 1,000
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Not applicableStudy completedNCT07560930
What this trial is testing

Neuromuscular Strength Factors Influencing Vertical Jump Performance

Who this might be right for
Conditions or Focus of Study
Uludag University 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT04006262
What this trial is testing

Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.

Who this might be right for
Localized Oesogastric AdenocarcimonaMSI and or dMMR
GERCOR - Multidisciplinary Oncology Cooperative Group 32
Not applicableWithdrawnNCT03095950
What this trial is testing

Interpretation of Health News Items Reporting Results of Randomized Controlled Trials With or Without Spin by French-speaking Population

Who this might be right for
The Study Focus on no Specific Condition
Assistance Publique - Hôpitaux de Paris
Next Page